Related Experiment Video
Updated: Aug 29, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal
Florian Kühnel1, Lars Zender, Thomas Wirth
1Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Carl Neuberg Str. 1, 30625 Hannover, Germany.
Abstract:
Adenoviral gene expression that is repressed by p53 in nontransformed cells could provide a tumor-specific gene therapy approach for a large subset of tumors. Adenoviral infection in vivo induces stabilization of p53, which can be utilized for a strategy that includes p53-dependent expression of a transcriptional repressor and a target promoter,which is highly susceptible for transcriptional repression. Therefore, we constructed different versions of CMV-promoters (CMVgal) with binding sites for GAL4-DBD and investigated 11 GAL4-DBD fusion proteins to elucidate the most effective repressor domain to silence CMVgal activity. The transcriptional repressor GAL4-KRAB-A under control of a p53-dependent promoter facilitates strong CMVgal-mediated gene expression specifically in p53 mutant cells by a double-recombinant adenoviral vector (Ad-RGCdR). GAL4-KRAB-A mediates strong transcriptional repression of Ad-RGCdR in p53 wild-type cells, which could be further enhanced by preactivation of p53-signalling following low-dose chemotherapy prior to adenoviral infection. By utilizing p53 signalling involved in chemotherapy and adenoviral infection, more than 99% of Ad-RGCdR gene expression could be repressed in p53 wild-type cells. Controlled gene expression from CMVgal promoters by transcriptional repression utilizing functional p53 signalling thus provides a very effective tool for tumor-specific adenoviral gene therapy.
Insights
This study developed a tumor-specific gene therapy using adenoviral vectors. It leverages p53 pathway activation to control gene expression, achieving over 99% repression in normal cells for enhanced safety.
Area of Science:
- Oncolytic Virotherapy
- Molecular Biology
- Gene Therapy
Background:
- p53 tumor suppressor protein plays a critical role in cellular response to DNA damage.
- Adenoviral vectors are widely used in gene therapy but lack tumor specificity.
- Targeted gene expression is crucial for effective and safe cancer gene therapy.
Purpose of the Study:
- To develop a novel adenoviral gene therapy strategy for tumor-specific gene expression.
- To identify effective transcriptional repressors for controlling gene expression in a p53-dependent manner.
- To enhance tumor selectivity of adenoviral vectors by utilizing the p53 pathway.
Main Methods:
- Construction of CMV-driven adenoviral vectors (CMVgal) with GAL4-binding sites.
- Investigation of 11 GAL4-DNA binding domain (DBD) fusion proteins for transcriptional repression.
- Utilizing a p53-dependent promoter to control the expression of the GAL4-KRAB-A repressor.
- Employing double-recombinant adenoviral vectors (Ad-RGCdR) for gene delivery.
Main Results:
- GAL4-KRAB-A demonstrated potent repression of CMVgal activity in p53 wild-type cells.
- Adenoviral vector Ad-RGCdR showed p53-dependent gene expression, higher in p53 mutant cells.
- Preactivation of p53 signaling via chemotherapy enhanced repression in wild-type cells (>99%).
- Achieved significant tumor-specific gene expression control by leveraging p53 signaling.
Conclusions:
- Controlled gene expression via transcriptional repression is a viable strategy for tumor-specific adenoviral gene therapy.
- The p53 pathway can be effectively utilized to enhance the safety and specificity of adenoviral gene therapy.
- The developed Ad-RGCdR vector with GAL4-KRAB-A offers a promising tool for targeting cancers with functional p53 signaling.
Related Concept Videos
Abnormal Proliferation
Gene Therapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Immunotherapy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

